13C Metabolic Flux Analysis of Escherichia coli Engineered for GammaAminobutyrate Production
- 13C Metabolic Flux Analysis of Escherichia coli Engineered for GammaAminobutyrate Production
- 성창민; 임대균; 홍재성; 구본철; 오민규
- Issue Date
- BIOTECHNOLOGY JOURNAL
- VOL 15, NO 6, 1900346
- Escherichia coli is engineered for γaminobutyrate (GABA) production in glucose minimal medium. For this, overexpression of mutant glutamate decarboxylase (GadB) and mutant glutamate/GABA antiporter (GadC), as well as deletion of GABA transaminase (GabT), are accomplished. In addition, the carbon flux to the tricarboxylic acid cycle is engineered by the overexpression of gltA, ppc, or both. The overexpression of citrate synthase (CS), encoded by gltA, increases GABA productivity, as expected. Meanwhile, the overexpression of phosphoenolpyruvate carboxylase (PPC) causes a decrease in the rate of glucose uptake, resulting in a decrease in GABA production. The phenotypes of the strains are characterized by 13C metabolic flux analysis (13C MFA). The results reveal that CS overexpression increases glycolysis and anaplerotic reaction rates, as well as the citrate synthesis rate, while PPC overexpression causes little changes in metabolic fluxes, but reduces glucose uptake rate. The engineered strain produces 1.2 g L？1 of GABA from glucose. Thus, by using 13C MFA, important information is obtained for designing metabolically engineered strains for efficient GABA production.
- Appears in Collections:
- KIST Publication > Article
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.